Data / Form D filings / AMICUS THERAPEUTICS, INC.
AMICUS THERAPEUTICS, INC.: Form D filings
AMICUS THERAPEUTICS, INC., a biotechnology company in Princeton, NJ, filed 7 Form D notices with the SEC between 2010 and 2023. The latest, on October 16, 2023, reports $30 million sold of a $30 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 47 Hulfish Street, Princeton, NJ, 08542
- Phone
- (609) 662-2000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1178879
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | New notice | $29,999,985 | $29,999,985 | 2 | Oct 5, 2023 | sec.gov | |
| Oct 13, 2021 | New notice | $199,916,500 | $199,916,500 | 9 | Sep 29, 2021 | sec.gov | |
| Jul 19, 2016 | New notice | $4,706,000 | $4,706,000 | 18 | Jul 5, 2016 | sec.gov | |
| Dec 3, 2013 | New notice | $15,000,000 | $15,000,000 | 5 | Nov 20, 2013 | sec.gov | |
| Dec 3, 2013 | New notice | $15,000,000 | $15,000,000 | 29 | Nov 19, 2013 | sec.gov | |
| Jul 30, 2012 | New notice | $18,582,360 | $18,582,360 | 1 | Jul 17, 2012 | sec.gov | |
| Nov 5, 2010 | New notice | $31,284,583 | $31,284,583 | 1 | Oct 28, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John F Crowley | Director | |
| David Clark | Executive Officer | |
| Eiry W Roberts, M.D. | Director | |
| Ellen S. Rosenberg | Executive Officer | |
| Margaret G. McGlynn | Director | |
| Craig A Wheeler | Director | |
| Michael A Kelly | Director | |
| Bradley Campbell | Executive Officer, Director | |
| Michael G Raab | Director | |
| Simon Harford | Executive Officer | |
| Glenn P Sblendorio | Director | |
| Burke W Whitman | Director | |
| Lynn D Bleil | Director | |
| Jeffrey P. Castelli, Ph.D. | Executive Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Oct 16, 2023 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AMICUS THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.